Skip to main content
. 2022 May 9;13:866318. doi: 10.3389/fphar.2022.866318

FIGURE 3.

FIGURE 3

The proportion of polypharmacy and hyper-polypharmacy among ≥180 days use elderly by sex and age group (A, C): Polypharmacy, (B, D): Hyper-polypharmacy).